Connor, Clark & Lunn Investment Management (CC&L)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21,563
| Closed | -$177K | – | 1499 |
|
|
2022
Q3 | $177K | Buy |
+21,563
| New | +$177K | ﹤0.01% | 1003 |
|
|
2021
Q4 | – | Sell |
-14,742
| Closed | -$91K | – | 1264 |
|
|
2021
Q3 | $91K | Buy |
+14,742
| New | +$91K | ﹤0.01% | 987 |
|
|
2017
Q2 | – | Sell |
-1,850
| Closed | -$11K | – | 1011 |
|
|
2017
Q1 | $11K | Hold |
1,850
| – | – | ﹤0.01% | 891 |
|
|
2016
Q4 | $10K | Hold |
1,850
| – | – | ﹤0.01% | 873 |
|
|
2016
Q3 | $16K | Hold |
1,850
| – | – | ﹤0.01% | 823 |
|
|
2016
Q2 | $18K | Hold |
1,850
| – | – | ﹤0.01% | 854 |
|
|
2016
Q1 | $17K | Sell |
1,850
-1,580
| -46% | -$14.5K | ﹤0.01% | 815 |
|
|
2015
Q4 | $43K | Buy |
3,430
+1,400
| +69% | +$17.6K | ﹤0.01% | 794 |
|
|
2015
Q3 | $25K | Sell |
2,030
-1,170
| -37% | -$14.4K | ﹤0.01% | 701 |
|
|
2015
Q2 | $56K | Sell |
3,200
-3,960
| -55% | -$69.3K | ﹤0.01% | 607 |
|
|
2015
Q1 | $104K | Buy |
7,160
+1,670
| +30% | +$24.3K | ﹤0.01% | 533 |
|
|
2014
Q4 | $46K | Hold |
5,490
| – | – | ﹤0.01% | 566 |
|
|
2014
Q3 | $61K | Hold |
5,490
| – | – | ﹤0.01% | 533 |
|
|
2014
Q2 | $107K | Sell |
5,490
-130
| -2% | -$2.53K | ﹤0.01% | 510 |
|
|
2014
Q1 | $93K | Buy |
+5,620
| New | +$93K | ﹤0.01% | 654 |
|
|
2013
Q4 | – | Sell |
-3,580
| Closed | -$76K | – | 780 |
|
|
2013
Q3 | $76K | Buy |
+3,580
| New | +$76K | ﹤0.01% | 493 |
|